Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (3) : regulatory approval

Kaigene Licenses KG006 Autoimmune Drug to Taisho for Japan

Kaigene Licenses KG006 Autoimmune Drug to Taisho for Japan
07/31/2026 | Companies
Kaigene, Inc., a U.S. biotechnology company focused on developing next-generation antibody therapies for autoimmune diseases, has announced an exclusive licensing partnership with Taisho Pharmaceutical Co., Ltd., one of Japan's leading pharmaceutical companies. The agreement grants Taisho exclusive...
antibody therapeutics, autoimmune disease treatment, autoimmune disorders, autoimmune therapy, biologics, biotech licensing, biotechnology, Celltrion, clinical development, drug commercialization, drug licensing agreement, FcRn inhibitor, healthcare news, hFcRn inhibitor, immunology, innovative therapeutics, Japan pharmaceutical market, Japanese pharma, Kaigene, KG006, milestone payments, MRCT, Multi-Regional Clinical Trial, neonatal Fc receptor, next-generation antibodies, pharmaceutical partnership, Phase 3 clinical trial, regulatory approval, royalty agreement, Taisho Pharmaceutical

GROW Investment Group Secures ADGM Approval for Middle East Expansion

GROW Investment Group Secures ADGM Approval for Middle East Expansion
04/29/2026 | Companies
GROW Investment Group (GIG), a prominent Chinese asset management firm overseeing nearly $1.5 billion in assets worldwide, announced today that it has secured In-Principle Approval (IPA) from the Financial Services Regulatory Authority (FSRA) of Abu Dhabi Global Market (ADGM). The company...
Abu Dhabi, Abu Dhabi Financial Week, Abu Dhabi Global Market, ADGM, Arvind Ramamurthy, Bank Julius Baer, capital markets, China GCC relations, Chinese asset manager, Chinese capital markets, cross border investment, economic integration, family offices, financial ecosystem, financial hub, financial services, FSRA, GCC, GIG, global asset management, global financial center, global investments, GROW Investment Group, Gulf Cooperation Council, high net worth individuals, institutional investors, international finance, investment opportunities, Lighthouse hedge fund, Middle East expansion, offshore asset management, onshore asset management, regulatory approval, sovereign wealth funds, wealth management, William Ma

Pony.ai Launches Autonomous Ride Trials in Singapore

Pony.ai Launches Autonomous Ride Trials in Singapore
04/07/2026 | Companies
Pony AI Inc, a leading company in advancing and commercializing autonomous driving at scale, has announced that its self-driving mobility service in Singapore—run in partnership with ComfortDelGro—has secured regulatory clearance to begin its “by-invite” ride phase, the final step before opening to...
AI transportation, autonomous driving, autonomous mobility, China tech, ComfortDelGro, driverless technology, first mile last mile, future mobility, global expansion, mobility services, MRT connectivity, Pony.ai, Punggol, regulatory approval, robotaxi, self-driving cars, Singapore, smart transportation, transport innovation, urban mobility


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com